Lawsone encapsulated polylactic-co-glycolic acid nanoparticles modified with chitosan-folic acid successfully inhibited cell growth and triggered apoptosis in Panc-1 cancer cells.


Journal

IET nanobiotechnology
ISSN: 1751-875X
Titre abrégé: IET Nanobiotechnol
Pays: United States
ID NLM: 101303205

Informations de publication

Date de publication:
Jul 2023
Historique:
revised: 12 04 2023
received: 18 01 2023
accepted: 29 04 2023
medline: 31 7 2023
pubmed: 16 5 2023
entrez: 16 5 2023
Statut: ppublish

Résumé

The present research aims to encapsulate lawsone in polylactic-co-glycolic acid (PLGA) nanoparticles modified with folic acid (FA) and chitosan (CS) to study its anticancer effects against Panc-1 cells. The nanoparticles were analysed in means of shape/size and zeta potential index using scanning electron microscope and dynamic light scattering. High-performance liquid chromatography was applied to evaluate the lawsone entrapment efficacy. The authors performed acridine orange/propidium iodide staining and flow cytometry to monitor apoptosis induction and cell cycle arrest. The expressions of apoptosis-related genes (BAX and BCL-2) were assessed by real time PCR. Nanoparticle antioxidative and antibacterial activities were examined by DPPH/ABTS scavenging assay, disk diffusion method, and minimum inhibitory concentration and minimum bactericidal concentration evaluation. The NPs were 229.65 nm, the encapsulation efficiency was 81%. The concentration of lawsone that exerts 50% cell growth inhibition (IC

Identifiants

pubmed: 37191102
doi: 10.1049/nbt2.12139
pmc: PMC10374556
doi:

Substances chimiques

Polylactic Acid-Polyglycolic Acid Copolymer 1SIA8062RS
Chitosan 9012-76-4
lawsone TLH4A6LV1W
Polyglycolic Acid 26009-03-0
Folic Acid 935E97BOY8
Lactic Acid 33X04XA5AT
Glycols 0
glycolic acid 0WT12SX38S
bcl-2-Associated X Protein 0
Drug Carriers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

425-437

Informations de copyright

© 2023 The Authors. IET Nanobiotechnology published by John Wiley & Sons Ltd.

Références

Saudi J Biol Sci. 2021 Sep;28(9):5065-5073
pubmed: 34466084
Carbohydr Polym. 2017 Mar 1;159:39-47
pubmed: 28038752
Cell Biochem Funct. 2010 Dec 2;28(8):695-705
pubmed: 21104938
Int J Nanomedicine. 2014;9:1-15
pubmed: 24363556
Int J Nanomedicine. 2022 Jan 11;17:137-150
pubmed: 35046650
BMC Cancer. 2021 Jun 2;21(1):662
pubmed: 34078316
Anal Biochem. 2005 Mar 15;338(2):284-93
pubmed: 15745749
Nanomedicine (Lond). 2021 Sep;16(22):1937-1961
pubmed: 34431317
Biotechnol Adv. 2016 Jul-Aug;34(4):343-353
pubmed: 27071534
Z Naturforsch C J Biosci. 2004 Jul-Aug;59(7-8):468-76
pubmed: 15813363
Nat Rev Clin Oncol. 2020 Jun;17(6):349-359
pubmed: 32152484
Biomol Concepts. 2016 Aug 1;7(4):259-70
pubmed: 27505095
Int J Biol Macromol. 2019 Mar 1;124:478-491
pubmed: 30500508
Daru. 2018 Sep;26(1):11-17
pubmed: 30159762
Cytotechnology. 2019 Feb;71(1):461-473
pubmed: 30599074
Sci Rep. 2019 Jul 26;9(1):10878
pubmed: 31350436
Sci Rep. 2020 Jun 2;10(1):8954
pubmed: 32488154
Nutrients. 2019 Jun 07;11(6):
pubmed: 31181639
Eur J Pharmacol. 2010 Jun 25;636(1-3):52-8
pubmed: 20371243
Cancer Biother Radiopharm. 1998 Jun;13(3):185-8
pubmed: 10850354
Eur J Pharm Biopharm. 2008 May;69(1):1-9
pubmed: 17826969
Cancer Invest. 2020 Sep;38(8-9):476-485
pubmed: 32845783
Biomed Pharmacother. 2018 Jun;102:555-566
pubmed: 29597089
Carbohydr Polym. 2021 Nov 15;272:118482
pubmed: 34420741
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Sep 5;148:146-55
pubmed: 25879984
J Ethnopharmacol. 2021 Apr 24;270:113842
pubmed: 33460752
Biomed Res Int. 2013;2013:723158
pubmed: 24282819
J Colloid Interface Sci. 2015 May 1;445:243-251
pubmed: 25622049
Methods Enzymol. 2008;446:107-22
pubmed: 18603118
ACS Appl Mater Interfaces. 2015 Sep 23;7(37):20530-7
pubmed: 26366977
Asian Pac J Cancer Prev. 2014;15(2):517-35
pubmed: 24568455
Avicenna J Med Biotechnol. 2021 Apr-Jun;13(2):98-103
pubmed: 34012526
J Biochem Mol Toxicol. 2019 Nov;33(11):e22402
pubmed: 31576639
IET Nanobiotechnol. 2023 Jul;17(5):425-437
pubmed: 37191102
ChemMedChem. 2018 Sep 19;13(18):1854-1872
pubmed: 29927521
Theranostics. 2019 Oct 17;9(26):8018-8025
pubmed: 31754378
Molecules. 2022 Jul 15;27(14):
pubmed: 35889394
Molecules. 2022 Sep 06;27(18):
pubmed: 36144488
J Biomater Sci Polym Ed. 2022 Jul;33(10):1289-1307
pubmed: 35260045
Med Mol Morphol. 2018 Dec;51(4):237-243
pubmed: 29926190
Mol Pharm. 2021 Jan 4;18(1):87-100
pubmed: 33231464
Pharmaceutics. 2021 Jul 20;13(7):
pubmed: 34371789
Chem Phys Lipids. 2021 Sep;239:105123
pubmed: 34403685

Auteurs

Helia Ghafaripour (H)

Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Masoud Homayouni Tabrizi (M)

Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Ehsan Karimi (E)

Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Niloofar Barati Naeeni (N)

Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.

Articles similaires

Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Humans Neoplasms Male Female Middle Aged
Humans Middle Aged Female Male Surveys and Questionnaires
Humans Receptors, Antigen, T-Cell Proto-Oncogene Proteins p21(ras) Pancreatic Neoplasms T-Lymphocytes

Classifications MeSH